The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Transient Ischemic Attack Treatment Market Research Report 2025

Global Transient Ischemic Attack Treatment Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 2010158

No of Pages : 92

Ask Your Query
Synopsis
The global market for Transient Ischemic Attack Treatment was valued at US$ 7010 million in the year 2024 and is projected to reach a revised size of US$ 9540 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Transient ischemic attack (TIA) is a common cerebrovascular disease, known as a "minor stroke", and is an important warning signal for stroke. TIA is defined medically as a clinical symptom of focal neurological deficits caused by transient blood supply disorders to the brain, typically lasting within 1 hour, and with no evidence of acute cerebral infarction on imaging examinations. The treatment of TIA usually includes drug therapy, surgical treatment, and rehabilitation therapy. For non cardiogenic TIA patients, antiplatelet therapy is the cornerstone of acute phase drug therapy, and commonly used drugs include aspirin and clopidogrel. For TIA caused by cardioembolic embolism, anticoagulant therapy is the first choice, with representative drugs including warfarin, dabigatran, rivaroxaban, etc. For TIA patients with symptomatic carotid stenosis, carotid endarterectomy (CEA) and carotid artery stenting (CAS) are the main methods. Rehabilitation treatment includes blood pressure control, blood lipid regulation, blood glucose management, lifestyle intervention, and other aspects.
North American market for Transient Ischemic Attack Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transient Ischemic Attack Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Transient Ischemic Attack Treatment in Atherosclerotic Transient Ischemic Attack is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Transient Ischemic Attack Treatment include Bayer, Sanofi, Bristol Myers Squibb, Pfizer, Novartis, AstraZeneca, Roche, Siemens Healthineers, Johnson and Johnson, Boehringer Ingelheim, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transient Ischemic Attack Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transient Ischemic Attack Treatment.
The Transient Ischemic Attack Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transient Ischemic Attack Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transient Ischemic Attack Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Sanofi
Bristol Myers Squibb
Pfizer
Novartis
AstraZeneca
Roche
Siemens Healthineers
Johnson and Johnson
Boehringer Ingelheim
Stryker
Boston Scientific
Terumo
Medtronic
Tasly Pharmaceutical Group
Shenzhen Salubris Pharmaceuticals
CSPC Pharmaceutical Group
Simcere Pharmaceutical Group
Segment by Type
Drug Treatment
Surgical Treatment
Rehabilitation
Others
Segment by Application
Atherosclerotic Transient Ischemic Attack
Cardioembolic Transient Ischemic Attack
Hemodynamic Transient Ischemic Attack
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transient Ischemic Attack Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transient Ischemic Attack Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Treatment
1.2.3 Surgical Treatment
1.2.4 Rehabilitation
1.2.5 Others
1.3 Market by Application
1.3.1 Global Transient Ischemic Attack Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Atherosclerotic Transient Ischemic Attack
1.3.3 Cardioembolic Transient Ischemic Attack
1.3.4 Hemodynamic Transient Ischemic Attack
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transient Ischemic Attack Treatment Market Perspective (2020-2031)
2.2 Global Transient Ischemic Attack Treatment Growth Trends by Region
2.2.1 Global Transient Ischemic Attack Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transient Ischemic Attack Treatment Historic Market Size by Region (2020-2025)
2.2.3 Transient Ischemic Attack Treatment Forecasted Market Size by Region (2026-2031)
2.3 Transient Ischemic Attack Treatment Market Dynamics
2.3.1 Transient Ischemic Attack Treatment Industry Trends
2.3.2 Transient Ischemic Attack Treatment Market Drivers
2.3.3 Transient Ischemic Attack Treatment Market Challenges
2.3.4 Transient Ischemic Attack Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transient Ischemic Attack Treatment Players by Revenue
3.1.1 Global Top Transient Ischemic Attack Treatment Players by Revenue (2020-2025)
3.1.2 Global Transient Ischemic Attack Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Transient Ischemic Attack Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transient Ischemic Attack Treatment Revenue
3.4 Global Transient Ischemic Attack Treatment Market Concentration Ratio
3.4.1 Global Transient Ischemic Attack Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transient Ischemic Attack Treatment Revenue in 2024
3.5 Global Key Players of Transient Ischemic Attack Treatment Head office and Area Served
3.6 Global Key Players of Transient Ischemic Attack Treatment, Product and Application
3.7 Global Key Players of Transient Ischemic Attack Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transient Ischemic Attack Treatment Breakdown Data by Type
4.1 Global Transient Ischemic Attack Treatment Historic Market Size by Type (2020-2025)
4.2 Global Transient Ischemic Attack Treatment Forecasted Market Size by Type (2026-2031)
5 Transient Ischemic Attack Treatment Breakdown Data by Application
5.1 Global Transient Ischemic Attack Treatment Historic Market Size by Application (2020-2025)
5.2 Global Transient Ischemic Attack Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transient Ischemic Attack Treatment Market Size (2020-2031)
6.2 North America Transient Ischemic Attack Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transient Ischemic Attack Treatment Market Size by Country (2020-2025)
6.4 North America Transient Ischemic Attack Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transient Ischemic Attack Treatment Market Size (2020-2031)
7.2 Europe Transient Ischemic Attack Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transient Ischemic Attack Treatment Market Size by Country (2020-2025)
7.4 Europe Transient Ischemic Attack Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transient Ischemic Attack Treatment Market Size (2020-2031)
8.2 Asia-Pacific Transient Ischemic Attack Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transient Ischemic Attack Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Transient Ischemic Attack Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transient Ischemic Attack Treatment Market Size (2020-2031)
9.2 Latin America Transient Ischemic Attack Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transient Ischemic Attack Treatment Market Size by Country (2020-2025)
9.4 Latin America Transient Ischemic Attack Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transient Ischemic Attack Treatment Market Size (2020-2031)
10.2 Middle East & Africa Transient Ischemic Attack Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transient Ischemic Attack Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Transient Ischemic Attack Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Transient Ischemic Attack Treatment Introduction
11.1.4 Bayer Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Transient Ischemic Attack Treatment Introduction
11.2.4 Sanofi Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb Transient Ischemic Attack Treatment Introduction
11.3.4 Bristol Myers Squibb Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Transient Ischemic Attack Treatment Introduction
11.4.4 Pfizer Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Transient Ischemic Attack Treatment Introduction
11.5.4 Novartis Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Transient Ischemic Attack Treatment Introduction
11.6.4 AstraZeneca Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Transient Ischemic Attack Treatment Introduction
11.7.4 Roche Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.7.5 Roche Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Details
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers Transient Ischemic Attack Treatment Introduction
11.8.4 Siemens Healthineers Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.8.5 Siemens Healthineers Recent Development
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Details
11.9.2 Johnson and Johnson Business Overview
11.9.3 Johnson and Johnson Transient Ischemic Attack Treatment Introduction
11.9.4 Johnson and Johnson Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.9.5 Johnson and Johnson Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Details
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Transient Ischemic Attack Treatment Introduction
11.10.4 Boehringer Ingelheim Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.10.5 Boehringer Ingelheim Recent Development
11.11 Stryker
11.11.1 Stryker Company Details
11.11.2 Stryker Business Overview
11.11.3 Stryker Transient Ischemic Attack Treatment Introduction
11.11.4 Stryker Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.11.5 Stryker Recent Development
11.12 Boston Scientific
11.12.1 Boston Scientific Company Details
11.12.2 Boston Scientific Business Overview
11.12.3 Boston Scientific Transient Ischemic Attack Treatment Introduction
11.12.4 Boston Scientific Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.12.5 Boston Scientific Recent Development
11.13 Terumo
11.13.1 Terumo Company Details
11.13.2 Terumo Business Overview
11.13.3 Terumo Transient Ischemic Attack Treatment Introduction
11.13.4 Terumo Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.13.5 Terumo Recent Development
11.14 Medtronic
11.14.1 Medtronic Company Details
11.14.2 Medtronic Business Overview
11.14.3 Medtronic Transient Ischemic Attack Treatment Introduction
11.14.4 Medtronic Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.14.5 Medtronic Recent Development
11.15 Tasly Pharmaceutical Group
11.15.1 Tasly Pharmaceutical Group Company Details
11.15.2 Tasly Pharmaceutical Group Business Overview
11.15.3 Tasly Pharmaceutical Group Transient Ischemic Attack Treatment Introduction
11.15.4 Tasly Pharmaceutical Group Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.15.5 Tasly Pharmaceutical Group Recent Development
11.16 Shenzhen Salubris Pharmaceuticals
11.16.1 Shenzhen Salubris Pharmaceuticals Company Details
11.16.2 Shenzhen Salubris Pharmaceuticals Business Overview
11.16.3 Shenzhen Salubris Pharmaceuticals Transient Ischemic Attack Treatment Introduction
11.16.4 Shenzhen Salubris Pharmaceuticals Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.16.5 Shenzhen Salubris Pharmaceuticals Recent Development
11.17 CSPC Pharmaceutical Group
11.17.1 CSPC Pharmaceutical Group Company Details
11.17.2 CSPC Pharmaceutical Group Business Overview
11.17.3 CSPC Pharmaceutical Group Transient Ischemic Attack Treatment Introduction
11.17.4 CSPC Pharmaceutical Group Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.17.5 CSPC Pharmaceutical Group Recent Development
11.18 Simcere Pharmaceutical Group
11.18.1 Simcere Pharmaceutical Group Company Details
11.18.2 Simcere Pharmaceutical Group Business Overview
11.18.3 Simcere Pharmaceutical Group Transient Ischemic Attack Treatment Introduction
11.18.4 Simcere Pharmaceutical Group Revenue in Transient Ischemic Attack Treatment Business (2020-2025)
11.18.5 Simcere Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Transient Ischemic Attack Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Key Players of Rehabilitation
Table 5. Key Players of Others
Table 6. Global Transient Ischemic Attack Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Transient Ischemic Attack Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Transient Ischemic Attack Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Transient Ischemic Attack Treatment Market Share by Region (2020-2025)
Table 10. Global Transient Ischemic Attack Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Transient Ischemic Attack Treatment Market Share by Region (2026-2031)
Table 12. Transient Ischemic Attack Treatment Market Trends
Table 13. Transient Ischemic Attack Treatment Market Drivers
Table 14. Transient Ischemic Attack Treatment Market Challenges
Table 15. Transient Ischemic Attack Treatment Market Restraints
Table 16. Global Transient Ischemic Attack Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Transient Ischemic Attack Treatment Market Share by Players (2020-2025)
Table 18. Global Top Transient Ischemic Attack Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transient Ischemic Attack Treatment as of 2024)
Table 19. Ranking of Global Top Transient Ischemic Attack Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Transient Ischemic Attack Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Transient Ischemic Attack Treatment, Headquarters and Area Served
Table 22. Global Key Players of Transient Ischemic Attack Treatment, Product and Application
Table 23. Global Key Players of Transient Ischemic Attack Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Transient Ischemic Attack Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Transient Ischemic Attack Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Transient Ischemic Attack Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Transient Ischemic Attack Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Transient Ischemic Attack Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Transient Ischemic Attack Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Transient Ischemic Attack Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Transient Ischemic Attack Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Transient Ischemic Attack Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Transient Ischemic Attack Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Transient Ischemic Attack Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Transient Ischemic Attack Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Transient Ischemic Attack Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Transient Ischemic Attack Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Transient Ischemic Attack Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Transient Ischemic Attack Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Transient Ischemic Attack Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Transient Ischemic Attack Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Transient Ischemic Attack Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Transient Ischemic Attack Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Transient Ischemic Attack Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Transient Ischemic Attack Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Transient Ischemic Attack Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Bayer Company Details
Table 49. Bayer Business Overview
Table 50. Bayer Transient Ischemic Attack Treatment Product
Table 51. Bayer Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 52. Bayer Recent Development
Table 53. Sanofi Company Details
Table 54. Sanofi Business Overview
Table 55. Sanofi Transient Ischemic Attack Treatment Product
Table 56. Sanofi Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 57. Sanofi Recent Development
Table 58. Bristol Myers Squibb Company Details
Table 59. Bristol Myers Squibb Business Overview
Table 60. Bristol Myers Squibb Transient Ischemic Attack Treatment Product
Table 61. Bristol Myers Squibb Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 62. Bristol Myers Squibb Recent Development
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Transient Ischemic Attack Treatment Product
Table 66. Pfizer Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Transient Ischemic Attack Treatment Product
Table 71. Novartis Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Transient Ischemic Attack Treatment Product
Table 76. AstraZeneca Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Transient Ischemic Attack Treatment Product
Table 81. Roche Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Siemens Healthineers Company Details
Table 84. Siemens Healthineers Business Overview
Table 85. Siemens Healthineers Transient Ischemic Attack Treatment Product
Table 86. Siemens Healthineers Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 87. Siemens Healthineers Recent Development
Table 88. Johnson and Johnson Company Details
Table 89. Johnson and Johnson Business Overview
Table 90. Johnson and Johnson Transient Ischemic Attack Treatment Product
Table 91. Johnson and Johnson Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 92. Johnson and Johnson Recent Development
Table 93. Boehringer Ingelheim Company Details
Table 94. Boehringer Ingelheim Business Overview
Table 95. Boehringer Ingelheim Transient Ischemic Attack Treatment Product
Table 96. Boehringer Ingelheim Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 97. Boehringer Ingelheim Recent Development
Table 98. Stryker Company Details
Table 99. Stryker Business Overview
Table 100. Stryker Transient Ischemic Attack Treatment Product
Table 101. Stryker Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 102. Stryker Recent Development
Table 103. Boston Scientific Company Details
Table 104. Boston Scientific Business Overview
Table 105. Boston Scientific Transient Ischemic Attack Treatment Product
Table 106. Boston Scientific Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 107. Boston Scientific Recent Development
Table 108. Terumo Company Details
Table 109. Terumo Business Overview
Table 110. Terumo Transient Ischemic Attack Treatment Product
Table 111. Terumo Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 112. Terumo Recent Development
Table 113. Medtronic Company Details
Table 114. Medtronic Business Overview
Table 115. Medtronic Transient Ischemic Attack Treatment Product
Table 116. Medtronic Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 117. Medtronic Recent Development
Table 118. Tasly Pharmaceutical Group Company Details
Table 119. Tasly Pharmaceutical Group Business Overview
Table 120. Tasly Pharmaceutical Group Transient Ischemic Attack Treatment Product
Table 121. Tasly Pharmaceutical Group Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 122. Tasly Pharmaceutical Group Recent Development
Table 123. Shenzhen Salubris Pharmaceuticals Company Details
Table 124. Shenzhen Salubris Pharmaceuticals Business Overview
Table 125. Shenzhen Salubris Pharmaceuticals Transient Ischemic Attack Treatment Product
Table 126. Shenzhen Salubris Pharmaceuticals Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 127. Shenzhen Salubris Pharmaceuticals Recent Development
Table 128. CSPC Pharmaceutical Group Company Details
Table 129. CSPC Pharmaceutical Group Business Overview
Table 130. CSPC Pharmaceutical Group Transient Ischemic Attack Treatment Product
Table 131. CSPC Pharmaceutical Group Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 132. CSPC Pharmaceutical Group Recent Development
Table 133. Simcere Pharmaceutical Group Company Details
Table 134. Simcere Pharmaceutical Group Business Overview
Table 135. Simcere Pharmaceutical Group Transient Ischemic Attack Treatment Product
Table 136. Simcere Pharmaceutical Group Revenue in Transient Ischemic Attack Treatment Business (2020-2025) & (US$ Million)
Table 137. Simcere Pharmaceutical Group Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report


List of Figures
Figure 1. Transient Ischemic Attack Treatment Picture
Figure 2. Global Transient Ischemic Attack Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transient Ischemic Attack Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drug Treatment Features
Figure 5. Surgical Treatment Features
Figure 6. Rehabilitation Features
Figure 7. Others Features
Figure 8. Global Transient Ischemic Attack Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Transient Ischemic Attack Treatment Market Share by Application: 2024 VS 2031
Figure 10. Atherosclerotic Transient Ischemic Attack Case Studies
Figure 11. Cardioembolic Transient Ischemic Attack Case Studies
Figure 12. Hemodynamic Transient Ischemic Attack Case Studies
Figure 13. Transient Ischemic Attack Treatment Report Years Considered
Figure 14. Global Transient Ischemic Attack Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Transient Ischemic Attack Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Transient Ischemic Attack Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Transient Ischemic Attack Treatment Market Share by Players in 2024
Figure 18. Global Transient Ischemic Attack Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Transient Ischemic Attack Treatment Revenue in 2024
Figure 20. North America Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Transient Ischemic Attack Treatment Market Share by Country (2020-2031)
Figure 22. United States Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Transient Ischemic Attack Treatment Market Share by Country (2020-2031)
Figure 26. Germany Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Transient Ischemic Attack Treatment Market Share by Region (2020-2031)
Figure 34. China Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Transient Ischemic Attack Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Transient Ischemic Attack Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Transient Ischemic Attack Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Bayer Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 51. Bristol Myers Squibb Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 55. Roche Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 56. Siemens Healthineers Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 57. Johnson and Johnson Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 59. Stryker Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 60. Boston Scientific Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 61. Terumo Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 62. Medtronic Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 63. Tasly Pharmaceutical Group Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 64. Shenzhen Salubris Pharmaceuticals Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 65. CSPC Pharmaceutical Group Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 66. Simcere Pharmaceutical Group Revenue Growth Rate in Transient Ischemic Attack Treatment Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock